We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).
- Authors
Notcutt, W; Langford, R; Davies, P; Ratcliffe, S; Potts, R
- Abstract
Open-label studies are not ideal for providing robust evidence for long-term maintenance of efficacy of medicines, especially where medicines provide symptom relief and where long-term use of a placebo may be problematic and not ethical.
- Publication
Multiple sclerosis (Houndmills, Basingstoke, England), 2012, Vol 18, Issue 2, p219
- ISSN
1477-0970
- Publication type
Journal Article
- DOI
10.1177/1352458511419700